Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NK cell and macrophage effector functions encompass the specialized biological activities of innate immune cells responsible for the surveillance and elimination of pathogens and malignant cells (Vivier et al., 2011, Nature Immunology). Natural Killer (NK) cells primarily exert their effects through direct cytolytic activity using perforin and granzymes, as well as the secretion of pro-inflammatory cytokines like interferon-gamma (IFN-γ) (Abel et al., 2018, Frontiers in Immunology). Macrophages contribute to host defense through phagocytosis, production of reactive oxygen species, and the orchestration of inflammatory responses via cytokine release and antigen presentation (Wynn & Vannella, 2016, Immunity). These functions are central to the mechanism of action for many immunotherapies, such as monoclonal antibodies that facilitate antibody-dependent cellular cytotoxicity (ADCC) or agents designed to polarize macrophages from a pro-tumor (M2) to an anti-tumor (M1) phenotype (Mantovani et al., 2017, Nature Reviews Drug Discovery). Because this entry describes a broad set of physiological processes rather than a single molecular entity, it is classified as a functional category rather than a specific therapeutic target. Dysregulation of these effector functions is a hallmark of various pathologies, including cancer immune evasion and chronic inflammatory disorders (Gasteiger et al., 2017, Nature Reviews Immunology).
Modulation of innate immune cell activity through various molecular pathways, including Fc receptor engagement for ADCC, cytokine-mediated activation, or checkpoint inhibition to relieve immunosuppression.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NK cell and macrophage effector functions.